Balestrini, Simona http://orcid.org/0000-0001-5639-1969
Doccini, Viola http://orcid.org/0000-0002-5166-8401
Boncristiano, Alessandra http://orcid.org/0000-0003-4270-5781
Lenge, Matteo http://orcid.org/0000-0003-2848-621X
De Masi, Salvatore http://orcid.org/0000-0001-5889-9280
Guerrini, Renzo http://orcid.org/0000-0002-7272-7079
Article History
Accepted: 26 April 2022
First Online: 9 June 2022
Declarations
:
: No funding was received for the preparation of this article.
: Renzo Guerrini has acted as an investigator for studies with Zogenix, Biocodex, UCB, Angelini and Eisai Inc. He has been a speaker and on advisory boards for Zogenix, Biocodex, Novartis, Biomarin and GW Pharma, outside the submitted work. Simona Balestrini reports personal fees from Biocodex, Eisai and UCB Pharma, outside the submitted work. Viola Doccini received a travel grant from Biocodex, partly related to the submitted work. Alessandra Boncristiano, Matteo Lenge and Salvatore De Masi, do not have any relevant competing interests.
: Approval was obtained from the Paediatric Ethics Committee of the Tuscany Region. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: Written informed consent was obtained from all individual participants included in the study or their parents or legal guardians, as appropriate.
: Not applicable.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
: Not applicable.